Related Experiment Video

Updated: Aug 8, 2026

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
11:29

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

Published on: July 20, 2016

Higher levels of surface CD20 expression on circulating lymphocytes compared with bone marrow and lymph nodes in

Y O Huh1, M J Keating, H L Saffer

  • 1Departments of Hematopathology and Leukemia, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030-4009, USA.

American Journal of Clinical Pathology
|September 14, 2001
PubMed

Insights

CD20 antibody binding varies by sample site in B-cell cancers. Peripheral blood samples show higher CD20 levels than bone marrow or lymph nodes in B-cell chronic lymphocytic leukemia, impacting rituximab therapy efficacy.

Area of Science:

  • Hematology
  • Immunology
  • Oncology

Background:

  • The expression of the CD20 surface antigen on B-cell neoplasms is crucial for targeted therapies.
  • Understanding the differential expression of CD20 across various anatomical sites and B-cell malignancies is essential for optimizing treatment strategies.

Purpose of the Study:

  • To quantify the number of CD20 antibodies bound per cell (CD20 ABC) in different specimen types.
  • To investigate the variation in CD20 expression in B-cell chronic lymphocytic leukemia (B-CLL) and other B-cell diseases across bone marrow (BM), peripheral blood (PB), and lymph node aspirate (LNA) samples.
  • To assess the clinical relevance of these findings for rituximab therapy.

Main Methods:

  • Quantitative flow cytometry was employed to measure CD20 ABC.
  • Samples from patients with B-CLL and other B-cell lymphomas (splenic, mantle cell, follicular, hairy cell leukemia) were analyzed.

Main Results:

  • In B-CLL, CD20 ABC was significantly higher in PB (mean, 9,051) compared to BM (mean, 4,067) and LNA (mean, 3,951).
  • No significant difference in CD20 ABC was observed between BM and PB samples in splenic lymphoma, mantle cell lymphoma, or follicular lymphoma.
  • CD20 ABC levels varied by disease type, being lowest in B-CLL, higher in splenic, follicular, and mantle cell lymphomas, and highest in hairy cell leukemia.

Conclusions:

  • CD20 surface antigen expression differs based on specimen source in B-CLL.
  • Lower CD20 levels in BM and LNA compared to PB in B-CLL patients may influence the effectiveness of rituximab treatment.
  • These site-specific expression differences warrant consideration in the therapeutic application of CD20-targeted agents.

More Related Videos

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking11:39

Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking

Published on: October 23, 2019

Related Concept Videos

Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Lymphoid Cells and Tissues01:18

Lymphoid Cells and Tissues

Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
Primary Lymphoid Organs01:16

Primary Lymphoid Organs

Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...